Related Experiment Videos
Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificity
1Laboratoire de Biochimie-Enzymologie, INSERM U 140, CNRS LA 147, Institut Gustave Roussy, Villejuif, France.
Mutation Research
|November 1, 1988
Summary
Simple reversible intercalators, isopropyl-OPC (iPr-OPC) and 9-aminoacridine (9-AA), show sequence-specific mutagenic effects. These compounds specifically revert frameshift mutations in monotonous G:C base pair sequences.
Area of Science:
- Molecular biology
- Genetics
- Chemical mutagenesis
Background:
- Simple reversible intercalators like isopropyl-OPC (iPr-OPC) and 9-aminoacridine (9-AA) are known mutagens.
- Assessing their mutagenic potency and sequence specificity is crucial for understanding DNA damage and repair mechanisms.
Purpose of the Study:
- To evaluate the mutagenic potency of iPr-OPC and 9-AA in E. coli.
- To determine the sequence specificity of these intercalators on frameshift mutations.
- To elucidate the precise mechanism of reversion at the molecular level.
Main Methods:
- Utilized reversion assays in E. coli with plasmids containing specific frameshift mutations in the tetracycline resistance gene.
- Targeted mutations included +/- 2 frameshifts in alternating GC sequences and +/- 1 frameshift in guanine runs.
- Employed restriction fragment analysis to precisely determine mutation sizes and reversion events.
Main Results:
- Demonstrated sequence-specific mutagenesis for both iPr-OPC and 9-AA.
- Identified that these intercalators specifically revert frameshift mutations within monotonous G:C base pair sequences.
- Confirmed reversion mechanisms: -1 deletions for +1 frameshifts and +1 additions for -1 frameshifts.
Conclusions:
- iPr-OPC and 9-AA exhibit distinct sequence preferences for inducing mutations.
- The observed reversion mechanisms are directly linked to the base sequence specificity of the intercalators.
- Findings contribute to understanding the relationship between chemical structure, DNA sequence, and mutagenic outcomes.